Linganisha mbinu

	Utafiti wa Kimfumo wa Mapitio ya Vitabu kwa Kutumia Itifaki	Mapitio ya Haraka
Nyanja	Saintometriki	Saintometriki
Familia	Process / pipeline	Process / pipeline
Mwaka wa asili	1990s–2015 (Cochrane Handbook 1st ed. 1994; PRISMA-P 2015)	2000s (rapidly adopted after 2005; Cochrane guidance 2020–2021)
Mwanzilishi	Cochrane Collaboration; Moher et al. (PRISMA-P)	Developed and formalised by health technology assessment agencies and the Cochrane Collaboration
Aina	Evidence synthesis method with pre-specified protocol	Evidence synthesis review
Chanzo asilia	Higgins, J. P. T., Thomas, J., Chandler, J., Cumpston, M., Li, T., Page, M. J., & Welch, V. A. (Eds.). (2023). Cochrane Handbook for Systematic Reviews of Interventions (Version 6.4). Cochrane. Retrieved from https://training.cochrane.org/handbook	Garritty, C., Gartlehner, G., Nussbaumer-Streit, B., King, V. J., Hamel, C., Kamel, C., Affengruber, L., & Stevens, A. (2021). Cochrane Rapid Reviews Methods Group offers evidence-informed guidance to conduct rapid reviews. Journal of Clinical Epidemiology, 130, 13–22.
Majina mbadala	protocol-registered SLR, pre-registered systematic review, PROSPERO-registered systematic review, protocol-driven systematic review	rapid evidence review, accelerated systematic review, rapid evidence assessment, REA
Zinazohusiana	5	5
Muhtasari	A protocol-based systematic literature review is a systematic review conducted according to a fully pre-specified and publicly registered research protocol. By committing the review question, eligibility criteria, search strategy, and planned analyses to a registered document before data collection begins, this approach minimises post-hoc decision-making, selective outcome reporting, and the accumulation bias that can undermine the credibility of unregistered reviews. Registration platforms such as PROSPERO and the Open Science Framework provide permanent, time-stamped records of the protocol.	A rapid review is a streamlined form of systematic review that deliberately simplifies or omits certain steps — such as dual screening, exhaustive grey-literature search, or full risk-of-bias assessment — in order to deliver timely, policy-relevant evidence synthesis within weeks rather than years. It is increasingly used by health agencies, governments, and organisations facing urgent decision-making needs where a full systematic review is not feasible within the available time and resources.